News for 'life-sciences'

Indo-UK Life Sciences Innovation Corridor To Deepen Ties

Indo-UK Life Sciences Innovation Corridor To Deepen Ties

Rediff.com23 Apr 2026

A new MoU between the Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London has paved the way for deepening India-UK ties in the life sciences sector.

Pharma companies can claim GST input tax credit on free samples, expired goods from FY'28

Pharma companies can claim GST input tax credit on free samples, expired goods from FY'28

Rediff.com9 Oct 2026

The GST Council has approved a proposal allowing pharmaceutical companies to claim Input Tax Credit (ITC) on free samples and goods destroyed or written off due to expiry, effective from the next fiscal year. This move aims to support manufacturing, liquidity, and exports within the sector.

TCG's Cortex DC To Develop 2 GW AI-Ready Data Centres In India

TCG's Cortex DC To Develop 2 GW AI-Ready Data Centres In India

Rediff.com2 days ago

Cortex DC, a company of The Chatterjee Group (TCG), announced its entry into the data centre market with plans to develop 2 GW of AI-ready capacity across India over the next seven years. The initiative aims to meet the growing demand for high-performance computing, targeting hyperscalers, cloud service providers, and advanced AI workloads with a focus on speed, scale, and sustainable power.

How Rising CO2 Levels Impact Wheat Protein And Baking Quality

How Rising CO2 Levels Impact Wheat Protein And Baking Quality

Rediff.com5 days ago

A new study by the Leibniz Institute for Food Systems Biology reveals that higher atmospheric carbon dioxide levels significantly alter the protein composition of wheat. This change impacts baking quality and the tolerability of wheat products, with increased amylase/trypsin-inhibitors and decreased gluten proteins observed under elevated CO2 conditions. Researchers emphasise the need for crop adaptation focusing on quality characteristics.

Cipla faces fresh FDA blow, Pune warehouse drug licences cancelled

Cipla faces fresh FDA blow, Pune warehouse drug licences cancelled

Rediff.com2 Oct 2026

The Maharashtra Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla Pharma & Life Sciences Ltd's carrying and forwarding (C&F) warehouse in Pune. This action follows alleged violations related to packaging, storage, documentation, and recall of Reactin Plus Tablets, a Schedule H drug. The FDA cited issues like misbranding, inadequate storage conditions, and deficiencies in record-keeping, reiterating its commitment to ensuring medicine safety and compliance.

Hexaware Names Vivek Jetley New CEO To Drive AI Growth

Hexaware Names Vivek Jetley New CEO To Drive AI Growth

Rediff.com2 Sep 2026

Hexaware Technologies has announced Vivek Jetley as its CEO-Designate, succeeding Srikrishna Ramakarthikeyan. Jetley will take over on October 28, 2026, with a mandate to accelerate growth and scale the company's AI-led services globally, leveraging his extensive experience in AI and enterprise transformation.

How AI Is Poised To Transform Indian Healthcare

How AI Is Poised To Transform Indian Healthcare

Rediff.com8 Sep 2026

A report by Bain & Company and HealthQuad identifies remote patient monitoring, OT/ICU optimisation, and chronic disease management as key opportunities for Artificial Intelligence in Indian healthcare. The report highlights a shift from experimental AI to real-world applications, driven by government initiatives, increasing EMR adoption, and a robust startup ecosystem. AI's autonomous capabilities are rapidly advancing while costs decrease, creating significant growth potential for providers and startups.

FDA withdraws action on Pune Cipla unit, MCA eateries after HC rebuke

FDA withdraws action on Pune Cipla unit, MCA eateries after HC rebuke

Rediff.com29 Aug 2026

The Bombay High Court severely criticised the Maharashtra FDA for its "undue haste" and "high-handed" actions, forcing the regulator to withdraw orders against Cipla Pharma and five restaurants at the Mumbai Cricket Association premises. The court admonished the FDA for violating principles of natural justice and taking a "pedantic instead of pragmatic view," even threatening contempt action against officials.

Rs 1 Trillion Club Swells

Rs 1 Trillion Club Swells

Rediff.com2 Sep 2026

Newly listed companies Vedanta Aluminium Metal, SBI Funds Management and Manipal Health Enterprises have entered the Rs 1 trillion mcap list since March 2026.

TCS And Google Cloud Unveil Gemini Experience Centre In Mexico City

TCS And Google Cloud Unveil Gemini Experience Centre In Mexico City

Rediff.com11 Aug 2026

Tata Consultancy Services (TCS) and Google Cloud have inaugurated a new Gemini Experience Center (GEC) in Mexico City. This facility, the second in Latin America and ninth globally for TCS, is equipped with over 3,000 AI agents and aims to drive industry-specific AI solutions across various sectors. It will help organisations bridge the gap between AI experimentation and implementation, enhancing innovation and data-driven decision-making in the region.

Karnataka To Build Robust AI Ecosystem With Anthropic Partnership

Karnataka To Build Robust AI Ecosystem With Anthropic Partnership

Rediff.com6 Aug 2026

Karnataka Chief Minister D K Shivakumar met with AI major Anthropic to discuss a long-term partnership aimed at accelerating AI adoption across governance, education, healthcare, research, and the state's startup ecosystem. The collaboration focuses on deploying AI solutions responsibly, ensuring data privacy, and developing AI-focused skilling programmes and an AI University.

Anupam Rasayan Pioneers ETFA Production With Innovative Chemistry Platform

Anupam Rasayan Pioneers ETFA Production With Innovative Chemistry Platform

Rediff.com12 Jun 2026

Specialty chemicals maker Anupam Rasayan India Ltd has become the first company globally to commercialise Ethyl trifluoroacetate (ETFA) production using its proprietary continuous flow chemistry platform. This innovative technology offers significant advantages over traditional methods, and ETFA is a crucial component for pharmaceuticals, life sciences, and performance materials, with a global market estimated at USD 500-600 million.

Why India Is Central To Rockwell Automation's Global Growth Plans

Why India Is Central To Rockwell Automation's Global Growth Plans

Rediff.com15 Jul 2026

Rockwell Automation's CEO Blake Moret highlights India as the centrepiece of the company's Asian growth strategy, detailing its four-decade presence, significant employee base, and support for the 'Make in India' initiative. The company sees major opportunities in pharmaceuticals, automotive, food and beverage, and consumer products, with AI playing a crucial role in simplifying industrial automation and boosting productivity for Indian manufacturers, including MSMEs.

Indian drugmakers in no rush to shift to US despite tariff threat

Indian drugmakers in no rush to shift to US despite tariff threat

Rediff.com10 Aug 2026

Indian pharmaceutical companies are not rushing to relocate manufacturing to the United States despite former President Donald Trump's renewed threat of tariffs up to 200 per cent on imported generic drugs. Instead, they are leveraging existing US plants, contract manufacturers, and making selective investments in complex products while maintaining India as their primary production hub.

Maharashtra FDA Seizes Illegal Medicines Worth Over Rs 24 Lakh In Major Crackdown

Maharashtra FDA Seizes Illegal Medicines Worth Over Rs 24 Lakh In Major Crackdown

Rediff.com9 Jun 2026

The Maharashtra Food and Drug Administration (FDA) conducted three separate operations in Pune and Kolhapur, seizing illegal medicines worth over Rs 24 lakh. Actions included seizing allopathic medicines from an unlicensed firm and prescription drugs with improper promotional packaging, with the FDA vowing strict action against violators.

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Outbound M&A by Indian firms robust despite West Asia tensions: HSBC's Sharma

Rediff.com10 Jul 2026

Indian companies' overseas expansion plans are holding strong despite geopolitical tensions in West Asia, driven by structural factors like supply-chain diversification, free trade agreements, and market expansion, according to Ajay Sharma, managing director and head of banking at HSBC India.

TCS Partners with Anthropic to Accelerate Enterprise AI Adoption Across Industries

TCS Partners with Anthropic to Accelerate Enterprise AI Adoption Across Industries

Rediff.com11 Jun 2026

Tata Consultancy Services (TCS) has announced a global partnership with AI major Anthropic to help enterprises accelerate their adoption of artificial intelligence, including equipping 50,000 TCS employees with Anthropic's Claude AI models.

Govt Clears Cancer Drug Price Hike

Govt Clears Cancer Drug Price Hike

Rediff.com11 Jun 2026

'While higher prices may create some financial burden for patients and caregivers in the short term, uninterrupted access to treatment remains the greater priority.'

India's Demerger Trend Soars: Over $40 Billion in Deals in 2025

India's Demerger Trend Soars: Over $40 Billion in Deals in 2025

Rediff.com4 Jun 2026

Indian companies are increasingly opting for demergers, with 29 deals valued at over $40 billion in 2025 alone, marking a 10-year high, as promoters and boards recognise that markets favour focused businesses over complex conglomerates.

'Biotech Engineering Has Significant Potential'

'Biotech Engineering Has Significant Potential'

Rediff.com24 Jun 2026

rediffGURU Nayagam PP guides aspirants on how to pick the right career course and college based on their entrance scores and aptitude.

Adi Godrej's Son Pirojsha to Succeed Nadir Godrej as Group Chairperson

Adi Godrej's Son Pirojsha to Succeed Nadir Godrej as Group Chairperson

Rediff.com13 Apr 2026

Godrej Industries Group announces Pirojsha Godrej as the new chairperson, succeeding Nadir Godrej in August, marking a significant leadership transition within the conglomerate.

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Agilisium invests in AI to transform pharma, biotech and medical tech companies

Rediff.com18 Mar 2026

Agilisium has invested Rs 50 crore to help pharmaceutical, biotech, and medical technology companies operationalise artificial intelligence, introducing a new professional standard called Forward Deployment Experts (FDX).

Ex-Employees Accused Of Fraud In Government Tenders

Ex-Employees Accused Of Fraud In Government Tenders

Rediff.com1 May 2026

Two former employees of a Delhi-based pharmaceutical firm have been booked for allegedly cheating, forging documents and impersonating to secure government tenders, including supplies to Army hospitals.

King's College Offers Rs 6.44 Lakh Grant For Indian Students Only

King's College Offers Rs 6.44 Lakh Grant For Indian Students Only

Rediff.com22 May 2026

The University of Gloucestershire is looking for international student-athletes for funded study and training opportunities in the UK.

Cognizant's Technoverse Hackathon 2026 Aims to Upskill Engineering Students in AI

Cognizant's Technoverse Hackathon 2026 Aims to Upskill Engineering Students in AI

Rediff.com14 Apr 2026

Cognizant has announced the launch of Technoverse Hackathon 2026, a national platform for engineering students to demonstrate AI-powered problem-solving skills in various industries. The hackathon aims to bridge academic learning with real-world applications and promote innovation.

Hyderabad claims its place as global MNC destination

Hyderabad claims its place as global MNC destination

Rediff.com18 Feb 2026

Hyderabad is rapidly emerging as a strategic hub for multinational companies (MNCs) deepening their focus on artificial intelligence (AI), life sciences, and global capability centres (GCCs), supported by the city's strong pharmaceutical (pharma) base, deeptech talent pool, and a policy environment that encourages high-value investment.

Liverpool University and IISc Partner to Boost Research and Innovation

Liverpool University and IISc Partner to Boost Research and Innovation

Rediff.com16 Apr 2026

The University of Liverpool and the Indian Institute of Science (IISc) have established a joint seed fund to promote research and innovation collaborations in areas such as AI, biomedicine, quantum technology, and space.

Accel and Google's AI Fund Invest in Five Promising AI Startups

Accel and Google's AI Fund Invest in Five Promising AI Startups

Rediff.com16 Mar 2026

Accel and Google's AI Futures Fund have announced the five startups selected for the 2026 Atoms AI Cohort, focusing on enterprise, voice, and industrial AI solutions, with each startup receiving significant investment and resources.

Infosys Q4 Net Profit Surges 21% to Rs 8,501 Crore, Projects 1.5-3.5% Revenue Growth for FY27

Infosys Q4 Net Profit Surges 21% to Rs 8,501 Crore, Projects 1.5-3.5% Revenue Growth for FY27

Rediff.com23 Apr 2026

Infosys reported a 20.8 per cent increase in consolidated net profit to 8,501 crore for the January-March quarter of FY26, with revenue from operations rising 13.4 per cent to 46,402 crore. The IT major has guided for a 1.5 to 3.5 per cent revenue growth for FY27, driven by momentum in financial services, utilities, and emerging AI services, despite a volatile macroeconomic environment and geopolitical risks.

Pirojsha Godrej: 'Godrej Aims To Become Rs 5 Trillion Market-Cap Group In 5 Years'

Pirojsha Godrej: 'Godrej Aims To Become Rs 5 Trillion Market-Cap Group In 5 Years'

Rediff.com8 May 2026

'We are targeting a 2.5x to 3x increase in valuation by FY31.'

Wipro's $1 bn Olam deal, Mindsprint acquisition marks major strategic win

Wipro's $1 bn Olam deal, Mindsprint acquisition marks major strategic win

Rediff.com7 Apr 2026

Wipro, India's fourth-largest IT services company, has secured an eight-year deal with Singapore-based Olam group, valued at over $1 billion, and will also acquire Olam's IT and digital services arm, Mindsprint, for $375 million, marking one of its largest contracts to date.

India Inc Salary Hikes Hold Steady

India Inc Salary Hikes Hold Steady

Rediff.com7 Apr 2026

'Decisions on talent and rewards have shifted as employees and companies are operating in a buyer's market across most skill categories.'

IYCU: How To Fund Your Research Internship In Life Science

IYCU: How To Fund Your Research Internship In Life Science

Rediff.com5 Feb 2024

The Next-Gen Scientists Foundation programme offers an opportunity to fund internships for undergraduate and postgraduate students who wish to gain research experience in life sciences.

Kerala: First State To Have State 'Bacteria'

Kerala: First State To Have State 'Bacteria'

Rediff.com29 Jan 2026

'We have tags of state animals and birds. However, the invisible world of microbes is doing a lot of things for us in nature, not just for human beings but for the entire life.'

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651.5 cr

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651.5 cr

Rediff.com21 Sep 2023

Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore.

Cancer Therapies Break New Ground

Cancer Therapies Break New Ground

Rediff.com26 Dec 2025

'India is clearly moving toward more targeted treatment pathways in high-burden cancers.'

US lawmakers move resolution to end Trump tariffs on India

US lawmakers move resolution to end Trump tariffs on India

Rediff.com13 Dec 2025

Representatives Deborah Ross of North Carolina, Marc Veasey of Texas and Raja Krishnamoorthi of Illinois introduced the resolution on Friday in the House of Representatives to terminate Trump's national emergency authorising tariffs of up to 50 per cent on imports from India, helping to restore Congress' constitutional authority over trade.

What's in store for realty sector in 2026? A mixed bag

What's in store for realty sector in 2026? A mixed bag

Rediff.com2 Jan 2026

After three post-pandemic years of an upcycle, it was a mixed bag for the realty sector in 2025, with sales volumes in the residential real estate moderating across top cities, and commercial real estate and institutional investments emerging as standout performers. Residential: Volumes soften, value holds firm.

Wokhardt Life Sciences enlivened

Wokhardt Life Sciences enlivened

Rediff.com1 Apr 2003

Wokhardt Life Sciences surged on Tuesday after the company's results indicated that it had soared strongly into the black from losses in the previous corresponding quarter.

Nirma, 3 private equity firms in race to buy Glenmark Life Sciences

Nirma, 3 private equity firms in race to buy Glenmark Life Sciences

Rediff.com25 May 2023

Ahmedabad-based Nirma group and leading private equity firms have joined the race to acquire BSE-listed Glenmark Life Sciences. The acquisition by chemicals-to-cement major Nirma, if successful, would be a major boost for the health-care segment of the group, on the lines of its successful entry into the cement sector following its purchase of Lafarge India's assets for about Rs 9,400 crore in July 2016. It later followed up by buying Emami cement assets for Rs 5,500 crore in February 2020.